E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/19/2010 in the Prospect News High Yield Daily.

New Issue: Merge Healthcare prices $200 million 11¾% five-year notes at 97.266 to yield 12½%

By Paul A. Harris

St. Louis, April 19 - Merge Healthcare Inc. priced a $200 million issue of 11¾% five-year first-lien senior secured notes (B2/B+/) at 97.266 to yield 12½% on Monday, according to an informed source.

The yield printed on top of the yield talk. The reoffer price came in line with discount talk of approximately 3 points.

Morgan Stanley & Co. Inc. ran the books.

Proceeds will be used to pay a portion of the Amicas acquisition.

Merge is a Milwaukee-based medical software developer.

Issuer:Merge Healthcare Inc.
Face amount:$200 million
Proceeds:$194,532,000
Maturity:May 1, 2015
Securities:First-lien senior secured notes
Bookrunner:Morgan Stanley & Co. Inc.
Coupon:11¾%
Price:97.266
Yield:12½%
Spread:999 bps
Call features:Make-whole call at Treasuries plus 50 bps until May 1, 2013, then callable at 105.875, par on and after May 1, 2014
Trade date:April 19
Settlement date:April 28
Ratings:Moody's: B2
Standard & Poor's: B+
Distribution:Rule 144A and Regulation S with registration rights
Price talk:12½% area all-in yield with approximately 3 points OID
Marketing:Full roadshow

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.